E-LIB Suche - Ergebnisse für: Even, A.J.C.

1

147O Scope of NUT carcinomas (NC): An international multice..:

Becerra, M.V. Sanchez ; Knetki-Wroblewska, M. ; O'Reilly, S....
ESMO Open. 9 (2024) - p. 102542 , 2024

Link: https://doi.org/10.1016/..

2

186P Post-anti-PD1 tumor characterization of HPV-negative R..:

Van Der Elst, A. ; Saboya, D. Herrero ; Michon, L....
Immuno-Oncology and Technology. 20 (2023) - p. 100645 , 2023

Link: https://doi.org/10.1016/..

3

117TiP BGB-HNSCC-201 (NCT05909904): Phase II, open-label, m..:

Harrington, K.J. ; Guo, Y. ; Haddad, R....
Immuno-Oncology and Technology. 20 (2023) - p. 100659 , 2023

Link: https://doi.org/10.1016/..

4

Incidence of adverse events in older patients treated with ..:

Rached, L. ; Laparra, A. ; Aldea, M....
Journal of Geriatric Oncology. 14 (2023) 8 - p. S44-S45 , 2023

Link: https://doi.org/10.1016/..

5

PCR132 Correlation Between Quality of Life (QoL) of Patient..:

Baumstarck, K. ; Even, C. ; Grumberg, V....
Value in Health. 26 (2023) 12 - p. S474 , 2023

Link: https://doi.org/10.1016/..

6

Corrigendum to 'Salivary gland cancer: ESMO–European Refere..:

van Herpen, C. ; Vander Poorten, V. ; Skalova, A....
ESMO Open. 8 (2023) 5 - p. 101630 , 2023

Link: https://doi.org/10.1016/..

7

Systemic therapies for salivary gland carcinoma (excluding ..:

Sarradin, V. ; Digue, L. ; Vergez, S....
European Annals of Otorhinolaryngology, Head and Neck Diseases. , 2023

Link: https://doi.org/10.1016/..

8

Radiotherapy for salivary gland cancer: REFCOR recommendati..:

Thariat, J. ; Ferrand, F.-R. ; Fakhry, N....
European Annals of Otorhinolaryngology, Head and Neck Diseases. , 2023

Link: https://doi.org/10.1016/..

9

Systemic therapies for salivary gland cancer: Adenoid cysti..:

Ferrand, F.-R. ; Even, C. ; Chabrillac, E....
European Annals of Otorhinolaryngology, Head and Neck Diseases. , 2023

Link: https://doi.org/10.1016/..

10

Salivary gland cancer: ESMO–European Reference Network on R..:

van Herpen, C. ; Vander Poorten, V. ; Skalova, A....
ESMO Open. 7 (2022) 6 - p. 100602 , 2022

Link: https://doi.org/10.1016/..

11

PO-0973 Locoregional treatment of primary tumor in synchron..:

Tang, E. ; Nguyen, T. ; Haddy, N....
Radiotherapy and Oncology. 161 (2021) - p. S806-S807 , 2021

Link: https://doi.org/10.1016/..

12

PCN81 Cost-Effectiveness Analysis of Pembrolizumab for the ..:

Massetti, M. ; Even, C. ; Geoffrois, L....
Value in Health. 23 (2020) - p. S436 , 2020

Link: https://doi.org/10.1016/..

13

Long-term outcomes and safety after reirradiation in locall..:

Boustani, J. ; Ruffier, A. ; Moya-Plana, A....
Strahlentherapie und Onkologie. 197 (2020) 3 - p. 188-197 , 2020

Link: https://doi.org/10.1007/..

14

Durvalumab with or without tremelimumab in patients with re..:

Ferris, R.L. ; Haddad, R. ; Even, C....
Annals of Oncology. 31 (2020) 7 - p. 942-950 , 2020

Link: https://doi.org/10.1016/..

15

Safety and clinical activity of the Notch inhibitor, crenig..:

Even, C. ; Lassen, U. ; Merchan, J....
Investigational New Drugs. 38 (2019) 2 - p. 402-409 , 2019

Link: https://doi.org/10.1007/..